Arctic Bioscience AS (OSL:ABS) COGS-to-Revenue : 0.75 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS COGS-to-Revenue?

Arctic Bioscience AS's Cost of Goods Sold for the six months ended in Dec. 2024 was kr19.98 Mil. Its Revenue for the six months ended in Dec. 2024 was kr26.74 Mil.

Arctic Bioscience AS's COGS to Revenue for the six months ended in Dec. 2024 was 0.75.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Arctic Bioscience AS's Gross Margin % for the six months ended in Dec. 2024 was 25.27%.

Arctic Bioscience AS COGS-to-Revenue Historical Data

The historical data trend for Arctic Bioscience AS's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS COGS-to-Revenue Chart

Arctic Bioscience AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.74

0.76

0.66

0.71

0.73

Arctic Bioscience AS Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial							0.61	0.70	0.72	0.69	0.75

Arctic Bioscience AS COGS-to-Revenue Calculation

Arctic Bioscience AS's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	31.596	/	43.484
	=	0.73

Arctic Bioscience AS's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	19.98	/	26.737
	=	0.75

Arctic Bioscience AS (OSL:ABS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Arctic Bioscience AS's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	19.98 / 26.737
	=	25.27 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Arctic Bioscience AS COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Arctic Bioscience AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

9TD:Germany

Address

Industrivegen 42, Orsta, NOR, 6155

Website

https://www.arctic-bioscience.com

Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. The company is developing a novel, oral drug candidate (HRO350) for the treatment of mild-to-moderate psoriasis. The company operates geographically in Norway, Americas, Europe, and APAC, with majority of the revenue deriving from Europe.

Arctic Bioscience AS Headlines

No Headlines